Central Admixture Pharmacy Services, Inc. (CAPS), New Orleans, LA
Is Central Admixture Pharmacy Services, Inc. (CAPS) registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location.
Does Central Admixture Pharmacy Services, Inc. (CAPS) hold a Louisiana pharmacy license?
State board of pharmacy records for Louisiana are not checked: no license file or list of board actions was found on the board’s website when checked on November 10, 2026; its credential verification is an interactive search.
Has Central Admixture Pharmacy Services, Inc. (CAPS) had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 untitled letter (Mar 25, 2022) for Central Admixture Pharmacy Services, Inc. (CAPS). State board of pharmacy records for Louisiana are not checked: no license file or list of board actions was found on the board’s website when checked on November 10, 2026; its credential verification is an interactive search.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- Central Admixture Pharmacy Services, Inc. (CAPS)
- Location
- New Orleans, LA
- Type as FDA labels it
- Not stated
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 1
- Warning letters on FDA’s actions page
- 0
- Latest action on that page
- Mar 25, 2022
- FDA Data Dashboard inspections
- No matching site found
- State board records
- Not checked
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Central Admixture Pharmacy Services, Inc. (CAPS), with 2 dated actions.
| Document | |||
|---|---|---|---|
| Mar 25, 2022 | Untitled letter | Untitled Letter Issued 03/25/2022 | Not linked by FDA |
| May 24, 2021 | Form 483 | 483 Issued 05/24/2021 | Not linked by FDA |
A Form 483 lists investigator observations, not a final FDA determination. An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
No inspected site under this exact name and city was found in the FDA Data Dashboard on Nov 15, 2026, searching 12,593 US sites with a drug inspection ending Oct 1, 2008 to Oct 23, 2026. FDA may list the site under another legal name, so this is not a finding that it was never inspected.
State board of pharmacy records
State board of pharmacy records for Louisiana are not checked: no license file or list of board actions was found on the board’s website when checked on November 10, 2026; its credential verification is an interactive search.
Same name at other locations
FDA lists these records under the same name at another location. A shared name does not establish that they are the same firm.
- Central Admixture Pharmacy Services, Inc. (CAPS), San Diego, CA
- Central Admixture Pharmacy Services, Inc. (CAPS), Harahan, LA
- Central Admixture Pharmacy Services, Inc., Allentown, PA
- Central Admixture Pharmacy Services, Inc. (CAPS), Cranberry Township, PA
This page restates FDA’s lists. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
Records last pulled Nov 15, 2026. Every entry links to the original public record.